Lucy Chappell
#104,800
Most Influential Person Now
British obstetrician and the Chief Scientific Adviser at the UK Department of Health and Social Care
Lucy Chappell's AcademicInfluence.com Rankings
Lucy Chappellphilosophy Degrees
Philosophy
#9143
World Rank
#12658
Historical Rank
Logic
#6134
World Rank
#7618
Historical Rank
Download Badge
Philosophy
Lucy Chappell's Degrees
- Masters Medicine University of Oxford
Why Is Lucy Chappell Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lucy Chappell is a British professor of obstetrics at King’s College London and the Chief Scientific Adviser for the UK Department of Health and Social Care. As part of her CSA role, she oversees the National Institute for Health and Care Research as Chief Executive Officer. Her research areas include medical problems during pregnancy such as pre-eclampsia, and the safety of medicines in pregnancy.
Lucy Chappell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report (2020) (4350)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (1083)
- Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19 (2020) (1040)
- Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial (1999) (838)
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (516)
- Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis (2014) (486)
- A longitudinal study of biochemical variables in women at risk of preeclampsia. (2002) (381)
- Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia: A Prospective Multicenter Study (2013) (355)
- Association of Severe Intrahepatic Cholestasis of Pregnancy With Adverse Pregnancy Outcomes: A Prospective Population-Based Case-Control Study (2014) (352)
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial (2021) (351)
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (316)
- Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study (2008) (305)
- Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study (2009) (291)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial (2021) (282)
- Intrahepatic cholestasis of pregnancy (2009) (245)
- Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses (2019) (232)
- Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. (2002) (203)
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (201)
- Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. (2015) (172)
- Role of oxidative stress and antioxidant supplementation in pregnancy disorders. (2011) (168)
- Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (162)
- Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial (2012) (156)
- Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. (2016) (146)
- High Risk of Unexpected Late Fetal Death in Monochorionic Twins Despite Intensive Ultrasound Surveillance: A Cohort Study (2005) (145)
- Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial (2019) (143)
- Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial (2019) (134)
- Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance (2019) (133)
- Oxidative stress in pregnancy and reproduction (2016) (133)
- Urinary Proteomics for Prediction of Preeclampsia (2011) (133)
- Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study. (2019) (127)
- Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. (2015) (121)
- Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. (2016) (116)
- Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (116)
- Associations between Intimate Partner Violence and Termination of Pregnancy: A Systematic Review and Meta-Analysis (2014) (112)
- Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper. (2020) (109)
- Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum (2015) (88)
- The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid (2014) (85)
- Clinical practice guideline on pregnancy and renal disease (2019) (83)
- Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial (2019) (82)
- Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study (2011) (74)
- Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta‐Analysis (2017) (67)
- Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study (2016) (65)
- An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2 (2015) (64)
- High perinatal survival in monoamniotic twins managed by prophylactic sulindac, intensive ultrasound surveillance, and Cesarean delivery at 32 weeks' gestation (2006) (62)
- Postpartum management of hypertension (2013) (62)
- Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial (2017) (59)
- Serum Creatinine in Pregnancy: A Systematic Review (2018) (58)
- Prediction of pre‐eclampsia: review of reviews (2019) (58)
- Pre‐eclamptic toxaemia: the role of uterine artery Doppler (1998) (54)
- Interstitial laser therapy for fetal reduction in monochorionic multiple pregnancy: loss rate and association with aplasia cutis congenita (2008) (54)
- Combined diffusion‐relaxometry MRI to identify dysfunction in the human placenta (2018) (53)
- Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks׳ gestation in nulliparous women who subsequently develop preeclampsia (2015) (50)
- Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomised controlled trial (2019) (50)
- Abnormal liver function tests in pregnancy (2013) (49)
- Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis (2016) (49)
- A core outcome set for pre‐eclampsia research: an international consensus development study (2020) (49)
- Gestation-Specific Vital Sign Reference Ranges in Pregnancy. (2020) (48)
- Effectiveness of a Home-Based Counselling Strategy on Neonatal Care and Survival: A Cluster-Randomised Trial in Six Districts of Rural Southern Tanzania (2015) (46)
- Multi‐modal functional MRI to explore placental function over gestation (2018) (46)
- Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19). (2020) (46)
- Lack of consistency in research papers over the definition of pre‐eclampsia (1999) (43)
- Maternal and perinatal adverse outcomes in women with pre-eclampsia cared for at facility-level in South Africa: a prospective cohort study (2018) (42)
- Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. (2020) (38)
- Determination of Normal Ranges of Shock Index and Other Haemodynamic Variables in the Immediate Postpartum Period: A Cohort Study (2016) (38)
- Advising on travel during pregnancy (2011) (37)
- Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension. (2016) (37)
- Association of Proteinuria Threshold in Pre-Eclampsia with Maternal and Perinatal Outcomes: A Nested Case Control Cohort of High Risk Women (2013) (36)
- Accuracy validation of the Microlife 3AS1-2 blood pressure device in a pregnant population with low blood pressure (2015) (35)
- Prospective biomarkers in preterm preeclampsia: A review. (2018) (33)
- Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis (2021) (33)
- Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small‐for‐gestational‐age infant in women presenting with reduced symphysis–fundus height (2015) (33)
- Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study (2013) (33)
- Maternal deaths in the UK: pre-eclampsia deaths are avoidable (2017) (32)
- Prepregnancy care (2012) (32)
- Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre‐eclampsia (2005) (32)
- Prevention of pre-eclampsia (2001) (32)
- Pregnancy Outcome in Women with Chronic Kidney Disease (2011) (31)
- The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings (2018) (31)
- Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study (2016) (30)
- Effect of a novel vital sign device on maternal mortality and morbidity in low-resource settings: a pragmatic, stepped-wedge, cluster-randomised controlled trial (2019) (29)
- Reduced fetal movements (2018) (28)
- The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes (2020) (27)
- Comparison of three commercially available placental growth factor‐based tests in women with suspected preterm pre‐eclampsia: the COMPARE study (2018) (27)
- A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. (2019) (27)
- Prediction of Preeclampsia and Delivery of Small for Gestational Age Babies Based on a Combination of Clinical Risk Factors in High-Risk Women (2011) (27)
- Predicting delivery of a small‐for‐gestational‐age infant and adverse perinatal outcome in women with suspected pre‐eclampsia (2018) (26)
- The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant? (2009) (26)
- Improving the Pipeline for Developing and Testing Pharmacological Treatments in Pregnancy (2016) (26)
- Learning about maternal death and grief in the profession: a pilot qualitative study (2015) (26)
- Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. (2019) (24)
- Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: A prospective cohort study (2017) (24)
- Blood pressure monitoring in high-risk pregnancy to improve the detection and monitoring of hypertension (the BUMP 1 and 2 trials): protocol for two linked randomised controlled trials (2020) (24)
- Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis (2016) (24)
- Updates in Diagnosis and Management of Preeclampsia in Women with CKD. (2020) (23)
- Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations (2020) (23)
- Pregnancy-Related Acute Kidney Injury in Preeclampsia (2019) (22)
- Management of pregnant and postnatal women with pre-existing diabetes or cardiac disease using multi-disciplinary team models of care: a systematic review (2014) (22)
- T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia (2020) (22)
- HAEMONCHOSIS IN WHITE-TAILED DEER IN THE SOUTHEASTERN UNITED STATES1 (1980) (22)
- Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD (2019) (21)
- Pregnancy-Related Acute Kidney Injury in Preeclampsia Risk Factors and Renal Outcomes (2019) (20)
- Obstetric anal sphincter injury (2010) (20)
- Temporal Changes in Hypertensive Disorders of Pregnancy and Impact on Cardiovascular and Obstetric Outcomes. (2020) (20)
- Assessment of proteinuria in pregnancy (2008) (20)
- Include pregnant women in research—particularly covid-19 research (2020) (19)
- Preterm pre-eclampsia: What every neonatologist should know. (2017) (19)
- Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial (2020) (18)
- Perfusion and apparent oxygenation in the human placenta (PERFOX) (2019) (18)
- How should women be advised on weight management in pregnancy? (2012) (18)
- Chronic hypertension in pregnancy: impact of ethnicity and superimposed preeclampsia on placental, endothelial, and renal biomarkers. (2018) (18)
- Shock index thresholds to predict adverse outcomes in maternal hemorrhage and sepsis: A prospective cohort study (2019) (18)
- Development and evaluation of a novel Vital Signs Alert device for use in pregnancy in low-resource settings (2018) (17)
- Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES) (2018) (17)
- Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis (2009) (17)
- Is early induction or expectant management more beneficial in women with late preterm pre-eclampsia? (2015) (16)
- External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol (2017) (16)
- Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study. (2017) (16)
- Biomarkers of oxidative stress in pre-eclampsia. (2011) (16)
- Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study (2014) (15)
- Reducing maternal deaths from hypertensive disorders: learning from confidential inquiries (2019) (15)
- Temporal Trends in Pregnancy‐Associated Stroke and Its Outcomes Among Women With Hypertensive Disorders of Pregnancy (2020) (15)
- Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial. (2022) (15)
- Placental growth factor in suspected preterm pre‐eclampsia: a review of the evidence and practicalities of implementation (2020) (15)
- Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? (2018) (14)
- Should pregnant women sleep on their left? (2011) (14)
- Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial) (2018) (14)
- Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis. (2020) (14)
- Implementation of guidelines for multidisciplinary team management of pregnancy in women with pre-existing diabetes or cardiac conditions: results from a UK national survey (2017) (14)
- Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial. (2022) (14)
- Current prevalence of self-monitoring of blood pressure during pregnancy: the BUMP Survey (2020) (13)
- Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms. (2016) (13)
- Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension. (2018) (13)
- A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial (2021) (12)
- Operative delivery rates following induction of labour for obstetric cholestasis (2011) (12)
- Evaluation of a novel vital sign device to reduce maternal mortality and morbidity in low-resource settings: a mixed method feasibility study for the CRADLE-3 trial (2018) (12)
- The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach. (2017) (12)
- Uncertainties in Screening and Prevention of Group B Streptococcus Disease (2018) (12)
- The assessment of blood pressure in pregnant women: pitfalls and novel approaches. (2020) (12)
- Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study (2019) (11)
- Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (11)
- Data-Driven multi-Contrast spectral microstructure imaging with InSpect: INtegrated SPECTral component estimation and mapping (2021) (10)
- Exploring the effect of implementation and context on a stepped-wedge randomised controlled trial of a vital sign triage device in routine maternity care in low-resource settings (2019) (10)
- Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance (2020) (10)
- Successful pregnancy following mid-trimester evacuation through a transabdominal cervical cerclage (2011) (10)
- Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial) (2019) (10)
- Intervention planning and modification of the BUMP intervention: a digital intervention for the early detection of raised blood pressure in pregnancy (2019) (9)
- Blood pressure measurement in pregnancy (2015) (9)
- APPLAUSE: Automatic Prediction of PLAcental health via U-net Segmentation and statistical Evaluation (2020) (9)
- Predisposition to superimposed preeclampsia in women with chronic hypertension: endothelial, renal, cardiac, and placental factors in a prospective longitudinal cohort (2020) (9)
- Postpartum-Specific Vital Sign Reference Ranges (2021) (9)
- How placental growth factor detection might improve diagnosis and management of pre-eclampsia (2014) (9)
- Exploring the potential for introducing home monitoring of blood pressure during pregnancy into maternity care: current views and experiences of staff—a qualitative study (2020) (9)
- Are blood pressure level and variability related to pregnancy outcome? Analysis of control of hypertension in pregnancy study data. (2020) (9)
- Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study (2020) (8)
- The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network’s first protocol: deep phenotyping in three sub-Saharan African countries (2020) (8)
- InSpect: INtegrated SPECTral Component Estimation and Mapping for Multi-contrast Microstructural MRI (2019) (8)
- Multicenter Cohort Study, With a Nested Randomized Comparison, to Examine the Cardiovascular Impact of Preterm Preeclampsia (2021) (7)
- Creating biobanks in low and middle-income countries to improve knowledge – The PREPARE initiative (2018) (7)
- External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis (2020) (7)
- Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial. (2020) (7)
- Incidence and characteristics of pregnancy‐related death across ten low‐ and middle‐income geographical regions: secondary analysis of a cluster randomised controlled trial (2020) (7)
- T2* relaxometry to characterize normal placental development over gestation in-vivo at 3T (2019) (7)
- Markers of maternal cardiac dysfunction in pre-eclampsia and superimposed pre-eclampsia. (2019) (7)
- External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis (2020) (7)
- Standardising definitions for the pre-eclampsia core outcome set: A consensus development study. (2020) (7)
- Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. (2021) (7)
- Placental magnetic resonance imaging in chronic hypertension: A case-control study (2020) (7)
- Commentary: Controversies in management of diabetes from preconception to the postnatal period (2008) (7)
- Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study. (2021) (6)
- Understanding patterns in maternity care in the NHS and getting it right (2013) (6)
- Setting and techniques for monitoring blood pressure during pregnancy. (2017) (6)
- Short-term prediction of preeclampsia: how close are we? (2014) (6)
- The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) database: open-access data collection in maternal and newborn health (2020) (6)
- Effect of the CRADLE vital signs alert device intervention on referrals for obstetric haemorrhage in low-middle income countries: a secondary analysis of a stepped- wedge cluster-randomised control trial (2021) (6)
- CKD and Pregnancy Outcomes in Africa: A Narrative Review (2020) (6)
- Protein-creatinine ratio and albumin-creatinine ratio for the diagnosis of significant proteinuria in pregnant women with hypertension: Systematic review and meta-analysis of diagnostic test accuracy. (2021) (5)
- Urine protein concentration estimation for biomarker discovery. (2013) (5)
- Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial) (2020) (5)
- PRECISE pregnancy cohort: challenges and strategies in setting up a biorepository in sub-Saharan Africa (2020) (5)
- [42-OR]: Diagnostic accuracy of placental growth factor in women with chronic kidney disease or hypertension and suspected preeclampsia: A prospective cohort study (2015) (5)
- Improving Knowledge on Safety is Key to Enabling Drug Access for Pregnant and Breastfeeding Women (2021) (5)
- Anti-Müllerian hormone concentrations in women with chronic kidney disease (2019) (5)
- Respiration resolved imaging with continuous stable state 2D acquisition using linear frequency SWEEP (2019) (5)
- Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters (2020) (5)
- What is the evidence for using labetalol as a first-line treatment option for hypertension in pregnancy? (2018) (5)
- Postpartum blood pressure self-management following hypertensive pregnancy: protocol of the Physician Optimised Post-partum Hypertension Treatment (POP-HT) trial (2022) (4)
- Two‐year follow‐up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre‐eclampsia (PHOENIX): A randomised controlled trial (2022) (4)
- The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies (2020) (4)
- Predicting pre-eclampsia (2015) (3)
- PP051. Budget impact analysis of maternal plasma PIGF concentrations in women with suspected pre-eclampsia: The potential for improved health service usage. (2013) (3)
- Planned delivery to improve postpartum cardiac function in women with preterm pre-eclampsia: the PHOEBE mechanisms of action study within the PHOENIX RCT (2021) (3)
- Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio. (2021) (3)
- Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies (2022) (3)
- In‐Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology (2022) (3)
- Recent Advances in Pre-Eclampsia and Eclampsia (2004) (3)
- Rule-in thresholds for DELFIA Xpress PlGF 1-2-3 test for suspected pre-eclampsia. (2020) (3)
- PP027. Alterations in maternal antioxidant micronutrient concentrations in women prior to developing pre-eclampsia. (2013) (3)
- OP 2 Placental growth factor informed management of suspected pre-eclampsia and/or fetal growth restriction (2017) (3)
- PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia (2019) (3)
- Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records (2022) (3)
- Vitamin supplementation in pregnancy (2012) (3)
- Planned delivery or expectant management in pre-eclampsia: an individual participant data meta-analysis. (2022) (3)
- Implementation of national antenatal hypertension guidelines: a multicentre multiple methods study (2020) (3)
- Intrahepatic cholestasis of pregnancy (2022) (3)
- Visual assessment of the placenta in antenatal magnetic resonance imaging across gestation in normal and compromised pregnancies: Observations from a large cohort study. (2021) (3)
- The contribution of qualitative research within the PRECISE study in sub-Saharan Africa (2020) (3)
- Transplacental metoprolol for fetal supraventricular tachycardia (2019) (3)
- Plasma Placental Growth Factor (PlGF) in the diagnosis of women with pre-eclampsia requiring delivery within 14 days: the PELICAN study (2013) (3)
- Why is the search for pre-eclampsia prevention so elusive? (2018) (3)
- Quality framework for remote antenatal care: qualitative study with women, healthcare professionals and system-level stakeholders. (2022) (2)
- Facilitating participation in clinical trials during pregnancy (2023) (2)
- O293 PITCH: URSODEOXYCHOLIC ACID VERSUS PLACEBO, AND EARLY DELIVERY VERSUS EXPECTANT MANAGEMENT IN THE MANAGEMENT OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY: TWO RANDOMISED CONTROLLED TRIALS (2012) (2)
- Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study (2021) (2)
- Research policy for people with multiple long-term conditions and their carers (2022) (2)
- In-Hospital Complications in Pregnant Women With Current or Historical Cancer Diagnoses. (2021) (2)
- Ursodeoxycholic acid to reduce adverse perinatal outcomes for intrahepatic cholestasis of pregnancy: the PITCHES RCT (2020) (2)
- Detection of additional abnormalities or co-morbidities in women with suspected intrahepatic cholestasis of pregnancy (2020) (2)
- Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2) (2022) (2)
- Women’s attitudes, beliefs and values about tests, and management for hypertensive disorders of pregnancy (2021) (2)
- Prediction of delivering a small for gestational age infant and adverse perinatal outcome in women with suspected pre-eclampsia (2018) (2)
- The role of antenatal corticosteroids in improving neonatal outcomes (2021) (2)
- Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy. (2018) (2)
- Effect of antioxidant supplementation on pre-labour rupture of the membranes (2011) (2)
- Data-Driven Multi-contrast Spectral Microstructure Imaging with InSpect (2020) (2)
- Maternal nutritional risk factors for pre-eclampsia incidence: findings from a narrative scoping review (2022) (2)
- A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study. (2021) (2)
- OP 35 Incidence of pre-eclampsia in the UK in 2016–17 (2017) (1)
- Low urinary aldosterone in pregnancy: a diagnostic tool for pre-eclampsia and superimposed pre-eclampsia? (2015) (1)
- Irrational testing for antiphospholipid antibodies (2013) (1)
- Hypertensive disorders of pregnancy and impact on in-hospital cardio-obstetric outcomes (2020) (1)
- Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy? (2022) (1)
- PP046. A unique urinary proteome profile at 15 weeks' gestation in low-risk women with subsequent pre-eclampsia. (2013) (1)
- Optimising timing of steroid administration in preterm pre-eclampsia. (2022) (1)
- Factors influencing perinatal outcomes in women with preterm preeclampsia: A secondary analysis of the PHOENIX trial. (2021) (1)
- Self-monitoring of blood pressure in pregnancy: A mixed methods evaluation of a national roll-out in the context of a pandemic (2022) (1)
- [208-POS]: An accurate semi-automated oscillometric blood pressure device for use in pregnancy, including pre-eclampsia, in a low- and middle-income country population: The Microlife 3AS1-2 (2015) (1)
- Caring for women with chronic hypertension (2019) (1)
- 273. Adverse perinatal outcomes of intrahepatic cholestasis of pregnancy and association with biochemical markers: Results of aggregate and independent patient data meta-analyses (2018) (1)
- Commentary on 'Preconception health care and congenital disorders: mathematical modelling of the impact of a preconception care programme on congenital disorders'. (2013) (1)
- A diagnostic panel of urinary biomarkers for pre-eclampsia in low and high-risk women (2014) (1)
- The effectiveness of decision aids for pregnancy related decision-making in women with pre-pregnancy morbidity; systematic review and meta-analysis (2022) (1)
- Adherence with blood pressure self-monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP (2021) (1)
- 9 Pregnancy and chronic hypertension: Nifedipine vs labetalol as antihypertensive treatment (the panda study) (2016) (1)
- Renal biopsy findings during and after pregnancy (2020) (1)
- SELF-MONITORING OF BLOOD PRESSURE IN WOMEN WITH PREGNANCY HYPERTENSION: THE BUMP2 MULTICENTRE RANDOMISED CONTROLLED TRIAL (2021) (1)
- Anti-Müllerian hormone concentrations in women with chronic kidney disease (2020) (1)
- Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX) (2022) (1)
- Intrahepatic cholestasis: suggested future investigations – Authors' reply (2019) (1)
- The Potential Role of Urinary Proteomics in the Prediction of Preeclampsia (2008) (1)
- Placental Growth Factor Testing to Assess Women With Suspected Preeclampsia: A Multicenter, Pragmatic, Stepped-Wedge Cluster-Randomized Controlled Trial (2019) (1)
- Self-monitoring blood pressure in hypertensive pregnancies: the OPTIMUM-BP pilot randomised-controlled trial (2019) (1)
- Anisotropy in the Human Placenta in Pregnancies Complicated by Fetal Growth Restriction (2021) (1)
- Monitoring the safety of COVID-19 vaccination in pregnancy in the UK: A national study using the UK Obstetric Surveillance System (UKOSS), UK Teratology Information Service (UKTIS) and Vaccination in Pregnancy (VIP) safety monitoring systems (2022) (1)
- Liver: Links between hepatobiliary diseases in and beyond pregnancy (2013) (1)
- An efficient and combined placental T1 ‐ADC acquisition in pregnancies with and without pre‐eclampsia (2021) (1)
- Cardiac and placental imaging (CARP) in pregnancy to assess aetiology of preeclampsia (2022) (1)
- WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic (2022) (1)
- Commentary: Complex medical conditions in pregnancy need appropriate multidisciplinary input (2009) (0)
- Spatial T2* MRI measures as a marker of oxygenation – assessment in healthy pregnancies over gestation (2019) (0)
- 248. Optimising the monitoring and management of raised blood pressure during and after pregnancy - developing an self-monitoring intervention in the English NHS (2018) (0)
- Use of Urinary Proteomics as Potential for Prediction of Pre-Eclampsia (2009) (0)
- Y-014. Two-year infant and maternal outcomes after planned delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial (2021) (0)
- Markers of endothelial and placental dysfunction are increased from the second trimester onwards in women with subsequent pre-eclampsia (1999) (0)
- 138. Placental growth factor to assess and diagnose hypertensive pregnant women: A stepped wedge randomised controlled trial (PARROT) (2018) (0)
- Author’s response to reviews Title: Intervention planning and modification of the BUMP intervention: a digital intervention for the early detection of raised blood pressure in pregnancy Authors: (2019) (0)
- smoking early in pregnancy : prospective cohort gestational age infants in women who stop Spontaneous preterm birth and small for (2009) (0)
- Prognostic indicators of severe disease in women with late preterm preeclampsia to guide decision making on timing of delivery: development and validation of prognostic models (2020) (0)
- Urinary Proteomics to Predict Pre-Eclampsia (2010) (0)
- Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT. (2022) (0)
- Test performance of fullPIERS and placental growth factor as prognostic tools for predicting the occurrence of adverse events associated with pre-eclampsia (2015) (0)
- Placental Growth Factor Testing for Suspected Preeclampsia: a Cost-Minimisation Analysis (2019) (0)
- Urinary congophilia in women with pre-eclampsia and chronic kidney disease (2016) (0)
- The Renal Association Clinical Practice Guideline on Pregnancy аnd Renal Disease (2019) (0)
- P-094. Self-monitoring of blood pressure in women with pregnancy hypertension: The BUMP2 multicentre randomised controlled trial (2021) (0)
- P23 Development of workflow for quantitative urinary proteomics using TMT™ labelling for potential biomarker discovery (2010) (0)
- Correction to paper (2017) (0)
- O130. Urinary congophilia in women with preeclampsia and chronic kidney disease (2015) (0)
- Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism (2022) (0)
- Prepare: A Stepped Wedge Cluster Randomised Trial to Evaluate Whether a Risk Stratification Model Can Reduce Preterm Deliveries Among Women with Suspected or Confirmed Preterm Pre-Eclampsia (2022) (0)
- Research in Maternal Medicine (2017) (0)
- 419. Detection of additional abnormalities or co-morbidities in women with intrahepatic cholestasis of pregnancy (2018) (0)
- SP110REDUCED URINARY ALDOSTERONE IN PRE-ECLAMPSIA, SUPERIMPOSED PRE-ECLAMPSIA COMPARED TO STANDARD- AND HIGH-RISK PREGNANT WOMEN (2015) (0)
- Management of a new pregnancy in a woman with chronic hypertension (2016) (0)
- Placental Growth Factor Testing to Assess Women With Suspected Preeclampsia: A Multicentre, Pragmatic, Stepped-wedge Cluster-randomized Controlled Trial (2020) (0)
- POS-234 PREGNANCY-ASSOCIATED PROGRESSION OF CHRONIC KIDNEY DISEASE: DEVELOPMENT OF A CLINICAL PREDICTIVE TOOL (2021) (0)
- Evaluation of existing birth weight centile standards for the purpose of identifying small for gestational age (SGA) twin neonates with associated morbidity/mortality (2011) (0)
- Managing hypertensive pregnancies (2016) (0)
- Characterisation of placental, fetal brain and maternal cardiac structure and function in pre-eclampsia using MRI (2023) (0)
- Authors' reply (2017) (0)
- P 41 Diagnostic biomarkers in women with CKD and superimposed pre-eclampsia (2017) (0)
- Editor Profiles (2008) (0)
- Correlating deaths due to household pollution from solid fuel and incidence of eclampsia in eight low and middle-income countries (2019) (0)
- Postnatal health and care following hypertensive disorders in pregnancy: a prospective cohort study (BPiPP study) (2022) (0)
- Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia : a prospective cohort study Shortened title : Early warning system hypertension thresholds (2017) (0)
- P-069. Planned delivery or expectant management for the prevention of adverse pregnancy outcomes in pre-eclampsia: A meta-analysis of individual participant data (2021) (0)
- The Vitamins in Pre-eclampsia Study (2001) (0)
- Pregnancy Outcome in Women with Proteinuria and/or Renal Impairment (2008) (0)
- Clinical and Geographic Variation in Use of Prophylactic and Therapeutic Treatments for Pre-Eclampsia (2009) (0)
- Corrigendum to "The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach" [Pregn. Hypertens. 12 (2018) 161-168]. (2019) (0)
- Obstetric patient safety indicator may be invalid (2018) (0)
- Pre-eclampsia (2009) (0)
- OR additional features as listed earlier Chronic hypertension Primary or secondary causes of hypertension Chronic kidney disease According to the Kidney Disease Outcomes Quality Initiative guidelines before pregnancy OR persistent proteinuria (2016) (0)
- Title Prospective biomarkers in preterm preeclampsia : a review Author ’ s names (2018) (0)
- Chapter 6 External validation of prognostic models for recurrence of hypertensive disorders of pregnancy in a pooled dataset of observational cohorts (2015) (0)
- Identification of a novel urinary proteomic signature at time-of-disease in women with pre-eclampsia (2011) (0)
- Uncertainties: Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? This paper is based on a research priority identified and commissioned by the National Institute for Health Research’s Health Technology Assessment programme on an important clini (2018) (0)
- 363. Characteristics of women with preterm pre-eclampsia enrolled to the PREPARE Trial – Preliminary data (2018) (0)
- OP 17 Performance of commercially available placental growth factor kits in women with suspected or confirmed pre-eclampsia (2017) (0)
- Pregnancy Outcomes in Patients with Myeloproliferative Neoplasms in the United Kingdom (2015) (0)
- "Currently, delivery is the only cure, and preeclampsia remains the leading reason for iatrogenic preterm delivery." (2014) (0)
- In Reply. (2021) (0)
- Maternal micronutrient status, antioxidant activity and oxidative stress markers at 15 weeks gestation women who subsequently develop pre-eclampsia (2014) (0)
- 175 The use of transition transfer documents to facilitate transition for young people with neurodevelopmental health needs to adult services (2021) (0)
- Managing late preterm pre-eclampsia – Authors' reply (2020) (0)
- CLINICAL ACUTE KIDNEY INJURY 1 (2014) (0)
- THU0184 Identification of biomarkers in SLE pregnancies using urinary proteomics (2013) (0)
- 288. Obstetric and renal outcomes of pregnant women with chronic kidney disease (CKD) stages 3–5 (2018) (0)
- Pregnancy-related Acute Kidney Injury in pre-eclampsia: risk factors and renal outcomes Running headline: Pr-AKI in pre-eclampsia (2019) (0)
- Authors' reply re: Incidence and characteristics of pregnancy‐related death across ten low‐ and middle‐income geographical regions: secondary analysis of a cluster randomised controlled trial (2020) (0)
- O65. Is there evidence to inform antihypertensive prescribing in pregnancy complicated by chronic hypertension: A systematic review (2015) (0)
- T2 and T2* placental magnetic resonance imaging in chronic hypertension (CHTN) (2019) (0)
- Vitamin supplementation in women at high risk of pre-eclampsia is associated with decreased oxidative stress, improved placental function and clinical outcome (2002) (0)
- POS-186 AMLODIPINE AS AN ALTERNATIVE ANTIHYPERTENSIVE IN PREGNANCY: A SYSTEMATIC REVIEW (2021) (0)
- Recommended micronutrient supplementation in pregnancy (2010) (0)
- 492 Ursodeoxycholic acid and perinatal outcomes in intrahepatic cholestasis of pregnancy: an individual patient data meta-analysis (2021) (0)
- OP 3 Assessment of the added value of early pregnancy 24-h ambulatory blood pressure monitoring for the prediction of pre-eclampsia in women with chronic hypertension (2017) (0)
- Placental growth factor testing in suspected pre-eclampsia – Authors' reply (2020) (0)
- Reduced urinary aldosterone in preeclampsia, superimposed pre-eclampsia compared to standard- and high-risk pregnant women (2015) (0)
- 242. Preeclampsia and premature cardiovascular disease in a large UK pregnancy cohort (2018) (0)
- 51. Prevalence of eclampsia in low-resource countries: Secondary analysis of a pragmatic stepped wedge cluster randomised controlled trial (2018) (0)
- Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a summary of the PITCHES study and its clinical implications (2020) (0)
- Placental Growth Factor in Suspected Preterm Pre-eclampsia: A Review of the Evidence and Practicalities of Implementation (2020) (0)
- 197. Markers of maternal cardiac dysfunction in pre-eclampsia and superimposed pre-eclampsia (2018) (0)
- P-077. Self-monitoring of blood pressure in women with higher risk pregnancies: The BUMP1 multicentre randomised controlled trial (2021) (0)
- Intrahepatic Cholestasis of Pregnancy: Toward Improving Perinatal Outcome (2021) (0)
- Planned delivery or expectant management for late preterm pre-eclampsia: a randomised controlled trial (PHOENIX) (2019) (0)
- Adverse perinatal outcomes in intrahepatic cholestasis of pregnancy and association with bile acids: Individual patient data meta-analysis to establish bile acid thresholds for risk of stillbirth and other perinatal outcomes (2018) (0)
- The impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study: Ethnicity and chronic hypertension in pregnancy (2018) (0)
- Vascular endothelial cell dysfunction in pre-eclampsia: a role for oxidative stress? (2000) (0)
- O125. Ethnicity: An independent risk factor for adverse perinatal outcome in women with chronic hypertension (2015) (0)
- 636: Plasma placental growth factor (PlGF) in the diagnosis of women with pre-eclampsia requiring delivery within 14 days: the PELICAN study (2013) (0)
- Re:Influenza vaccination in pregnancy (2017) (0)
- PlacentalGrowthFactor(PlGF)inWomen withSuspectedPre-EclampsiaPriorto35 Weeks'Gestation:ABudgetImpactAnalysis (2016) (0)
- What Threshold of Proteinuria Indicates Increased Risk in Hypertensive Pregnancies (2008) (0)
- Corrigendum to "Visual assessment of the placenta in antenatal magnetic resonance imaging across gestation in normal and compromised pregnancies: Observations from a large cohort study" [117 January 2022 29-38]. (2022) (0)
- Antithrombotic therapy in pregnancy (2017) (0)
- OP05.14: Interstitial intrafetal laser for selective and non‐selective reduction in complicated monochorionic multiple pregnancies (2006) (0)
- Self-monitoring of blood pressure during pregnancy: the BUMP trials (2019) (0)
- Poston, Lucilla and Igosheva, Natalia and Mistry, Hiten D. and Seed, Paul T. and Shennan, Andrew H. and Rana, Sarosh and Karumanchi, S. Ananth and Chappell, (2017) (0)
- Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation. (2022) (0)
- Validation of the BPro radial pulse waveform acquisition device in pregnancy and gestational hypertensive disorders (2021) (0)
- Does genetically-defined ancestry predict booking blood pressure in pregnant women with chronic hypertension? (2019) (0)
- A qualitative study of the dynamics of access to remote antenatal care through the lens of candidacy. (2023) (0)
- Antioxidants and pre-eclampsia (2000) (0)
- 289. Self-monitoring BP in hypertensive pregnancies: The OPTIMUM-BP pilot study (2018) (0)
- Adverse Maternal and Perinatal Outcomes Associated with Multiple Pregnancies: A Prospective Study (2009) (0)
- 230. Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy (2018) (0)
- Ursodeoxycholic acid for adverse perinatal outcomes – Authors' reply (2020) (0)
- Antioxidants and pre-eclampsia - Reply (2000) (0)
- Placental Growth Factor Informed Management of Suspected Pre-eclampsia or (2018) (0)
- 586: Risk profiles for normotensive and hypertensive small for gestational age (SGA) infants include different clinical and ultrasound indices - data from the SCOPE study (2011) (0)
This paper list is powered by the following services:
Other Resources About Lucy Chappell
What Schools Are Affiliated With Lucy Chappell?
Lucy Chappell is affiliated with the following schools:
